Vice Chair, Research & Professor, Infectious Diseases
Dr. E. B. Flink Chair of Research
- Behavioral Medicine & Psychiatry
- Department of Neuroscience
- MD, Rush Medical College
Feinberg J. The Rural Opioid Initiative Consortium description: providing evidence to Understand the Fourth Wave of the Opioid Crisis. Journal: Addiction Science and Clinical Practice. DOI: 10.1186/s13722-022-00322-5. Published online July 26, 2022
Stover AN, Winstanley EL, Zhang Y, Feinberg J. The impact of rural classification systems on a comparison of risky drug-related behaviors in Kentucky and Ohio counties. Journal of Human Behavior in the Social Environment. Published online Jan 9, 2019. doi.org/10.1080/10911359.2018.1516591.
Kushner T, Tressler S, Chen Z, Kaufman H, Jones-López EC, Feinberg J, Terrault NA. Changes in prevalence of hepatitis B virus infection among reproductive-aged women and children under 3 years of age in the United States, 2011-2017. Clin Inf Dis, published online August 26, 2019. doi.org/10.1093/cid/ciz841.
Winstanley EL, Stover AM, Feinberg J. Concurrent alcohol and opioid use among harm reduction clients. Addictive Behaviors. Published online Nov. 5, 2019. PMID: doi.org/10.1016/j.addbeh.2019.06.016
Feinberg J. World View: Tackle the epidemic, not the opioids. Nature, September 12, 2019; 573:165.
Litwin AH, Jost J, Wagner K, Heo M, Karasz A, Feinberg J, Kim AY, Lum PJ, Mehta SH, Taylor LE, Tsui JI, Pericot-Valverde I, Page K, and the HERO Study Group. Rationale and design of a randomized pragmatic trial of patient-centered models of hepatitis C treatment for people who inject drugs: the HERO study. Contemporary Clinical Trials 2019; 87:105859. doi.org/10.1016/j.cct.2019.105859.
Krakower DS, Daskalakis DC, Feinberg J, Marcus JL. Tenofovir alafenamide for HIV preexposure prophylaxis — what can we DISCOVER about its true value? Ann Intern Med, published online January 14, 2020. doi: 10.7326/M19-3337.
Cafardi JM, Haas D, Lamarre T, Feinberg J. Brucella endocarditis in persons who inject drugs. Open Forum Infectious Diseases, 2020; 7(4); ofaa063; https://doi.org/10.1093/ofid/ofaa063.
Tressler S, Lilly C, Gross D, Hulsey T, Feinberg J. Variations in hepatitis B vaccine series completion by setting among adults at risk in West Virginia. American Journal of Preventive Medicine, 2020; 59(5):e189-e196. doi: 10.1016/j.amepre.2020.05.022.
Hodder SL, Feinberg J, Strathdee SA, Shoptaw S, Altice FL, Ortenzio L, Beyrer C. The U.S. opioid crisis and HIV: deadly synergies. (In print, Lancet, Nov 2020.)
Burrell CN, Sharon MJ, Davis SM, Feinberg J, Nist J, Lander O, Boley V, Burns J, Wojcik E, Martin IBK. Using the electronic medical record to increase testing for HIV and hepatitis C virus in an Appalachian emergency department. (Submtted, BMJ Public Health, August 2020.)
Pollini RA, Paquette CE, Drvar T, Marshalek P, Ang-Rabanes M, Feinberg J, Haut MW. A qualitative assessment of discharge against medical advice among patients hospitalized for injection-related bacterial infections in West Virginia. (Submitted, Journal of Addiction Medicine, July 2020.)
O’Brien TC, Feinberg J, Gross R, Albarracin D. Creating supportive environments to curb the opioid epidemic: how perceptions of providers’ support for intervention strategies might shape patient-provider interactions. (Submitted, Social Science and Medicine, July 2020.)
Zibbell JE, Pieper NC, Duhart Clarke SE, Salazar ZR, Vincent LB, Feinberg J, Kral AH. Consumer discernment of fentanyl in street-purchased opioid products confirmed by fentanyl test strips: lessons from a syringe services program in North Carolina. (Submitted, Addictive Behaviors, October 2020.)
Honors and Achievements
2020 You Make a Difference Award, Community Liver Alliance, Pittsburgh
2015 Cincinnati Healthcare Hero, finalist and winner, Community Outreach
American College of Physicians (Fellow)
Infectious Diseases Society of America (Fellow)
American Society for Microbiology
American Association for the Advancement of Science
International AIDS Society
International Society for Antiviral Research
Society for Clinical Trials
American Academy of HIV Medicine
HIV Medical Association
International Network on Hepatitis in Substance Users
American Public Health Association
College on Problems of Drug Dependence
About Judith Feinberg
In 2005, Dr. Feinberg was the first physician in metropolitan Cincinnati to recognize that opioid injection drug use had emerged as a health threat, based on increased admissions for infective endocarditis. She became involved in harm reduction efforts and, in 2014, after a nine-year effort she established Ohio's 3rd syringe exchange and its 1st true syringe services program, the Cincinnati Exchange Project.
West Virginia has the highest rates of acute hepatitis B, acute hepatitis C, Neonatal Abstinence Syndrome, and overdose deaths in the U.S. After a long career in HIV/AIDS, she came to WVU in late 2015 to focus on ending these opioid-related epidemics at their epicenter. As Professor of Behavioral Medicine & Psychiatry and Professor of Medicine/Infectious Diseases, she is working hard to turn the tide on opioid misuse and opioid-related epidemics. She has federal funding from National Institute on Drug Abuse, the Patient-Centered Outcomes Research Initiative, the Appalachian Regional Commission, and state funding from the WV Bureau for Public Health for these efforts. Dr. Feinberg was recently named the first E.B. Flink Vice Chair for Research in the Department of Medicine.